Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2013 by Andaluz Health Service
Sponsor:
Information provided by (Responsible Party):
Juan Macías, Andaluz Health Service
ClinicalTrials.gov Identifier:
NCT01900015
First received: July 12, 2013
Last updated: July 15, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)